Showing results (61-70 of 124) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2018
Impact of Emergent Circulating Tumor DNA <i>RAS</i> Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal CancerTae Won Kim, Marc Peeters, Anne Thomas, et al.British Journal of Cancer|July 18, 2018
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trialsMarc Peeters, Timothy Price, Julien Taieb, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2018
Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT StudyMarc Peeters, Timothy Price, Michael Boedigheimer, et al.European Journal of Cancer (Oxford, England : 1990)|October 8, 2016
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancerTimothy Price, Tae Won Kim, Jin Li, et al.Journal of Gastrointestinal Oncology|May 19, 2025
Efficacy observation of sequential TAS-102 following regorafenib as a later-line treatment in patients with metastatic colorectal cancer: a cohort studyChang Xu, Xiangyu Cheng, Changqing Liu, et al.Anticancer Research|February 27, 2026
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year StudyHarleen Kaur, Gershwin Isaac Singh Bhall, Christopher Lauder, et al.Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Small cell lung cancer: patterns of care and their influence on survival - 25 years experience of a single Australian oncology unitSarwan Bishnoi, Kenneth Pittman, Margaret Colbeck, et al.Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer RegistryAnas Alawawdeh, Timothy Price, Christos Karapetis, et al.Cancers|July 2, 2020
Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510GHiroya Taniguchi, Takeharu Yamanaka, Daisuke Sakai, et al.BMC Cancer|July 28, 2011
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyDusan Kotasek, Niall Tebbutt, Jayesh Desai, et al.Pageof 13